Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jacobs Solutions (J) Asset Writedowns and Impairment (2021 - 2024)

Historic Asset Writedowns and Impairment for Jacobs Solutions (J) over the last 4 years, with Q3 2024 value amounting to $3.0 million.

  • Jacobs Solutions' Asset Writedowns and Impairment fell 7009.57% to $3.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $3.0 million, marking a year-over-year decrease of 9377.44%. This contributed to the annual value of $3.0 million for FY2024, which is 9377.12% down from last year.
  • Latest data reveals that Jacobs Solutions reported Asset Writedowns and Impairment of $3.0 million as of Q3 2024, which was down 7009.57% from $10.0 million recorded in Q3 2023.
  • Jacobs Solutions' 5-year Asset Writedowns and Impairment high stood at $72.3 million for Q4 2021, and its period low was $914000.0 during Q2 2023.
  • Over the past 4 years, Jacobs Solutions' median Asset Writedowns and Impairment value was $6.9 million (recorded in 2022), while the average stood at $16.2 million.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first soared by 33913.04% in 2023, then plummeted by 7009.57% in 2024.
  • Quarter analysis of 4 years shows Jacobs Solutions' Asset Writedowns and Impairment stood at $72.3 million in 2021, then plummeted by 62.44% to $27.1 million in 2022, then tumbled by 63.04% to $10.0 million in 2023, then tumbled by 70.1% to $3.0 million in 2024.
  • Its Asset Writedowns and Impairment stands at $3.0 million for Q3 2024, versus $10.0 million for Q3 2023 and $914000.0 for Q2 2023.